Zumiez (ZUMZ) Guides Q2 EPS 14c Below Consensus; Wedbush Cuts Price Target
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Roth Capital Downgrades Zumiez, Inc. (ZUMZ) to Neutral
June 5, 2015 8:37 AM EDTRoth Capital downgraded Zumiez, Inc. (NASDAQ: ZUMZ) from Buy to Neutral with a price target of $29.00 (from $26.00).
Analyst Dave King commented, "1Q15 EPS met estimates but guidance missed due to weakness in April that accelerated through May. Management noted softer trends in seasonal... More
Mizuho Securities Cuts Price Target on Zumiez, Inc. (ZUMZ) Following Comp Miss and 2Q Guide
June 5, 2015 7:29 AM EDTMizuho Securities maintains a Neutral rating on Zumiez, Inc. (NASDAQ: ZUMZ), and cut the price target to $29.00 (from $35.00), following May comp and 2Q guide. May comps of (2.2)%, compared to +3.6% last year, missed Streets +2.6%. Analyst Betty Chen said that managements 2Q comp guidance of... More
Baird Downgrades Zumiez, Inc. (ZUMZ) to Neutral
June 5, 2015 6:52 AM EDTBaird downgraded Zumiez, Inc. (NASDAQ: ZUMZ) from Outperform to Neutral with a price target of $28.00 (from $42.00).
For an analyst ratings summary and ratings history on Zumiez, Inc. click here. For more ratings news on Zumiez, Inc. click here.
Shares of Zumiez, Inc. closed at $29.74 yesterday.
... MoreAfter-Hours Stock Movers 06/04: (PTN) (ARO) (ZOES) Higher; (ESL) (VNCE) (ZUMZ) Lower (more...)
June 4, 2015 5:59 PM EDTPalatin Technologies (NYSE: PTN) 25.6% HIGHER; an FDA panel voted to support approval of Sprout's female libido drug. Notably, Palatin's Bremelanotide is in advanced trials to treat female sexual dysfunction.
Esterline Technologies (NYSE: ESL) 10.1% LOWER; reported Q2 EPS of $0.69, $0.64 worse than the analyst estimate of $1.33. Revenue for the quarter came in at $500.1 million versus the consensus estimate of $534.7 million. Esterline Technologies sees FY2015 EPS of $4.55-$4.80, versus prior guidance of $5.35-$5.75. Esterline Technologies sees FY2015 revenue of $1.825-1.875... More
Zumiez, Inc. (ZUMZ) Reports In-Line Q1 EPS, Q2 Guidance Falls Short
June 4, 2015 4:07 PM EDTZumiez, Inc. (NASDAQ: ZUMZ) reported Q1 EPS of $0.12, in-line with the analyst estimate of $0.12. Revenue for the quarter came in at $177.6 million versus the consensus estimate of $179.3 million.
The Company's comparable sales decreased 2.2% for the four-week period ended May 30, 2015 compared to a comparable... More
Zumiez, Inc. (ZUMZ) Halted, News Pending
June 4, 2015 4:01 PM EDTZumiez, Inc. (NASDAQ: ZUMZ) Halted, News Pending
... MoreTrading Radar for 6/4: Smucker (SJM), Joy Global (JOY), Diamond Foods (DMND), Zoe's Kitchen (ZOES) Report
June 3, 2015 2:19 PM EDTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EDT
Earnings:
China Ceramics Co., Ltd. (Nasdaq:... More
